{"id":1423,"date":"2021-02-06T11:27:42","date_gmt":"2021-02-06T02:27:42","guid":{"rendered":"https:\/\/www.m.ehime-u.ac.jp\/school\/neurosurgery\/?p=1423"},"modified":"2021-02-06T11:27:42","modified_gmt":"2021-02-06T02:27:42","slug":"%e8%87%a8%e5%ba%8a%e7%a0%94%e7%a9%b6%e3%80%8c%e8%86%a0%e8%8a%bd%e8%85%ab%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8bbevacizumab%e3%81%ae%e6%9c%89%e7%94%a8%e6%80%a7%e3%81%a8%e6%8a%95%e4%b8%8e%e3%82%bf-2","status":"publish","type":"post","link":"https:\/\/www.m.ehime-u.ac.jp\/school\/neurosurgery\/1423","title":{"rendered":"\u81e8\u5e8a\u7814\u7a76\u300c\u81a0\u82bd\u816b\u306b\u304a\u3051\u308bBevacizumab\u306e\u6709\u7528\u6027\u3068\u6295\u4e0e\u30bf\u30a4\u30df\u30f3\u30b0\u306b\u95a2\u3059\u308b\u89b3\u5bdf\u7814\u7a76\u300d\u306e\u7d50\u679c\u5831\u544a\u306b\u3064\u3044\u3066"},"content":{"rendered":"<p>\u304a\u77e5\u3089\u305b<\/p>\n<p>\u611b\u5a9b\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662\u3067\u306f\u3001\u533b\u5b66\u30fb\u533b\u7642\u306e\u767a\u5c55\u306e\u305f\u3081\u306b\u69d8\u3005\u306a\u7814\u7a76\u3092\u884c\u3063\u3066\u3044\u307e\u3059\u3002\u305d\u306e\u4e2d\u3067\u4eca\u56de\u793a\u3057\u307e\u3059\u4ee5\u4e0b\u306e\u7814\u7a76\u3067\u306f\u3001\u4ee5\u524d\u306b\u304a\u77e5\u3089\u305b\u81f4\u3057\u307e\u3057\u305f\u3088\u3046\u306b\u3001\u5f53\u79d1\u306b\u3066\u52a0\u7642\u3092\u884c\u3063\u305f\u60a3\u8005\u3055\u3093\u306e\u30ab\u30eb\u30c6\u8a18\u9332\u3084\u753b\u50cf\u60c5\u5831\u3092\u4f7f\u7528\u81f4\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u7814\u7a76\u306b\u95a2\u3057\u3066\u306f\u5f53\u79d1\u306b\u3066\u89e3\u6790\u304c\u65e2\u306b\u7d42\u4e86\u3057\u3066\u304a\u308a\u3001\u300cCancer Medicine\u300d\u306b\u7d50\u679c\u3092\u516c\u8868\u81f4\u3057\u3066\u304a\u308a\u307e\u3059\u3002\u5185\u5bb9\u306e\u8a73\u7d30\u3092\u77e5\u308a\u305f\u3044\u65b9\u306f\u3001\u4e0b\u8a18\u3010\u304a\u554f\u3044\u5408\u308f\u305b\u5148\u3011\u307e\u3067\u3054\u9023\u7d61\u4e0b\u3055\u3044\u3002<\/p>\n<p>\u3010\u7814\u7a76\u8ab2\u984c\u540d\u3011<br \/>\n\u81a0\u82bd\u816b\u306b\u304a\u3051\u308bBevacizumab\u306e\u6709\u7528\u6027\u3068\u6295\u4e0e\u30bf\u30a4\u30df\u30f3\u30b0\u306b\u95a2\u3059\u308b\u89b3\u5bdf\u7814\u7a76<\/p>\n<p>\u3010\u7814\u7a76\u6a5f\u95a2\u3011\u611b\u5a9b\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662\u3000\u8133\u795e\u7d4c\u5916\u79d1<\/p>\n<p>\u3010\u7814\u7a76\u8cac\u4efb\u8005\u3011\u4e95\u4e0a\u660e\u5b8f\uff08\u611b\u5a9b\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662\u3000\u8133\u795e\u7d4c\u5916\u79d1\u3000\u8b1b\u5e2b\uff09<\/p>\n<p>\u3010\u7814\u7a76\u4ee3\u8868\u8005\u3011\u4e95\u4e0a\u660e\u5b8f\uff08\u611b\u5a9b\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662\u3000\u8133\u795e\u7d4c\u5916\u79d1\u3000\u8b1b\u5e2b\uff09<\/p>\n<p>\u3010\u7814\u7a76\u306e\u76ee\u7684\u3011<br \/>\n\u3000\u81a0\u82bd\u816b\u306e\u6cbb\u7642\u306b\u304a\u3044\u3066 DNA\u30e1\u30c1\u30eb\u5316\u5264\u30c6\u30e2\u30be\u30ed\u30df\u30c9\uff08TMZ\uff09\u306e\u5c0e\u5165\u306f\u5927\u304d\u306a\u30d6\u30ec\u30fc\u30af\u30b9\u30eb\u30fc\u3067\u3057\u305f\u304c\u3001TMZ \u8010\u6027\u75c7\u4f8b\u3082\u591a\u304f\u5316\u5b66\u7642\u6cd5\u5264\u5358\u72ec\u306b\u3088\u308b\u81a0\u82bd\u816b\u6cbb\u7642\u3078\u306e\u9650\u754c\u304c\u793a\u5506\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u4e00\u65b9\u3067\u3001\u816b\u760d\u751f\u7269\u5b66\u7684\u7279\u6027\u3092\u5229\u7528\u3057\u305f\u5206\u5b50\u6a19\u7684\u6cbb\u7642\u85ac\u3067\u3042\u308bBevacizumab\u306e\u6709\u52b9\u6027\u3082\u671f\u5f85\u3055\u308c\u3066\u3044\u307e\u3057\u305f\u304c\u3001\u75c5\u614b\u306e\u4e00\u6642\u7684\u306a\u6539\u5584\u52b9\u679c\u306f\u5f97\u3089\u308c\u308b\u3082\u306e\u306e\u6709\u610f\u306a\u751f\u5b58\u5ef6\u9577\u52b9\u679c\u306f\u78ba\u8a8d\u3055\u308c\u3066\u3044\u306a\u3044\u306e\u304c\u73fe\u72b6\u3067\u3059\u3002\u3057\u304b\u3057\u3001\u591a\u304f\u306e\u81a0\u82bd\u816b\u306e\u60a3\u8005\u3055\u3093\u306b\u304a\u3044\u3066Bevacizumab\u306e\u5c0e\u5165\u306b\u3088\u308a\u72b6\u614b\u304c\u5287\u7684\u306b\u6539\u5584\u3059\u308b\u3053\u3068\u306f\u4e8b\u5b9f\u3067\u3042\u308a\u3001\u81a0\u82bd\u816b\u306e\u4e2d\u306b\u306fBevacizumab\u306b\u8457\u3057\u304f\u8010\u6027\u3092\u6301\u3064\u30b5\u30d6\u30bf\u30a4\u30d7\u304c\u5b58\u5728\u3057\u3066\u3044\u308b\u306e\u3067\u306f\u306a\u3044\u304b\u3068\u8003\u3048\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u307e\u3067\u306e\u7814\u7a76\u306b\u304a\u3044\u3066\u3001\u6211\u3005\u306f\u81a0\u82bd\u816b\u306e\u6d78\u6f64\u5148\u7aef\u306b\u5b58\u5728\u3057\u3066\u3044\u308b\u816b\u760d\u5e79\u7d30\u80de\uff08cancer stem cell\uff1aCSC\uff09\u306e\u4e2d\u3067\u5e79\u7d30\u80de\u30de\u30fc\u30ab\u30fc\u3067\u3042\u308bCD44\u3092\u9ad8\u767a\u73fe\u3059\u308bCSC\u306f\u6d78\u6f64\u6027\u304c\u8457\u3057\u304f\u9ad8\u304f\u3001\u6cbb\u7642\u62b5\u6297\u6027\u3067\u3042\u308b\u3053\u3068\u3092\u8a3c\u660e\u3057\u307e\u3057\u305f\uff08M Nishikawa, A Inoue et al. Stem cell international\uff09\u3002\u3053\u306e\u3053\u3068\u304b\u3089\u3001CD44\u9ad8\u767a\u73fe\u306eCSC\u7531\u6765\u306e\u81a0\u82bd\u816b\u3053\u305d\u304cBevacizumab\u4e0d\u5fdc\u6027\u306e\u81a0\u82bd\u816b\u3067\u306f\u306a\u3044\u304b\u3068\u306e\u8003\u3048\u306b\u81f3\u308a\u3001\u5f53\u9662\u3067\u7d4c\u9a13\u3057\u305fBevacizumab\u6295\u4e0e\u60a3\u8005\u306e\u6458\u51fa\u7d44\u7e54\u3092\u89e3\u6790\u3059\u308b\u3053\u3068\u3067\u3053\u306e\u4eee\u8aac\u3092\u8a3c\u660e\u3057\u305f\u3044\u3068\u8003\u3048\u3066\u3044\u307e\u3059\u3002\u3059\u306a\u308f\u3061\u3001\u672c\u7814\u7a76\u306f\u81a0\u82bd\u816b\u306e\u60a3\u8005\u3055\u3093\u306b\u304a\u3051\u308bBevacizumab\u62b5\u6297\u6027\u306e\u539f\u56e0\u3092\u89e3\u660e\u3057\u3001\u9069\u5207\u306aBevacizumab\u306e\u4f7f\u7528\u6642\u671f\u3092\u8a55\u4fa1\u3059\u308b\u3053\u3068\u3067\u3001\u81a0\u82bd\u816b\u306e\u65b0\u305f\u306a\u6cbb\u7642\u6226\u7565\u3092\u958b\u767a\u3059\u308b\u3053\u3068\u3092\u76ee\u7684\u3068\u3057\u307e\u3059\u3002<\/p>\n<p>\u3010\u7814\u7a76\u306e\u65b9\u6cd5\u3011<br \/>\n\uff08\u5bfe\u8c61\u3068\u306a\u308b\u60a3\u8005\u3055\u3093\uff092014\u5e744\u6708\u304b\u30892020\u5e7412\u6708\u306b\u611b\u5a9b\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662\u3092\u53d7\u8a3a\u3055\u308c\u305f\u65b9\u306e\u3046\u3061\u81a0\u82bd\u816b\u3068\u8a3a\u65ad\u3055\u308c\u305f\u60a3\u8005\u3055\u3093<br \/>\n\uff08\u5229\u7528\u3059\u308b\u30ab\u30eb\u30c6\u60c5\u5831\uff09\u6027\u5225\u3001\u5e74\u9f62\u3001\u767a\u75c7\u6642\u671f\u3001\u5408\u4f75\u75c7\u3001\u65e2\u5f80\u6b74\u3001\u8eab\u4f53\u6240\u898b\u3001\u8840\u6db2\u691c\u67fb\u30c7\u30fc\u30bf\u3001\u753b\u50cf\u691c\u67fb\u30c7\u30fc\u30bf\u3001\u6cbb\u7642\u72b6\u6cc1\u3001\u816b\u760d\u30c7\u30fc\u30bf\uff08\u907a\u4f1d\u60c5\u5831\u3092\u542b\u3080\uff09\u7b49<br \/>\n\uff08\u5229\u7528\u3059\u308b\u753b\u50cf\uff09\u901a\u5e38\u306e\u8a3a\u7642\u304a\u3088\u3073\u624b\u8853\u3067\u53d6\u5f97\u3057\u305f\u753b\u50cf<\/p>\n<p>\u3010\u7814\u7a76\u7d50\u679c\u306e\u516c\u8868\u3011<br \/>\nMasahiro Nishikawa, Akihiro Inoue, Takanori Ohnishi, Hajime Yano, Yonehiro Kanemura, Shohei Kohno, Shiro Ohue, Saya Ozaki, Shirabe Matsumoto, Satoshi Suehiro, Yawara Nakamura, Seiji Shigekawa, Hideaki Watanabe, Riko Kitazawa, Junya Tanaka, Takeharu Kunieda. (2021) CD44 expression in the tumor periphery predicts the responsiveness to bevacizumab in the treatment of recurrent glioblastoma. Cancer Medicine: 2021; 00: 1-13, doi: 10.1002\/CAM4.3767<\/p>\n<p>\u3010\u500b\u4eba\u60c5\u5831\u306e\u53d6\u308a\u6271\u3044\u3011<br \/>\n\u3000\u53ce\u96c6\u3057\u305f\u8a66\u6599\u30fb\u60c5\u5831\u306f\u540d\u524d\u3001\u4f4f\u6240\u306a\u3069\u60a3\u8005\u3055\u3093\u3092\u76f4\u63a5\u7279\u5b9a\u3067\u304d\u308b\u60c5\u5831\u3092\u9664\u3044\u3066\u533f\u540d\u5316\u3044\u305f\u3057\u307e\u3059\u3002\u500b\u4eba\u3092\u7279\u5b9a\u3067\u304d\u308b\u3088\u3046\u306a\u60c5\u5831\u304c\u5916\u306b\u6f0f\u308c\u308b\u3053\u3068\u306f\u3042\u308a\u307e\u305b\u3093\u3002\u307e\u305f\u3001\u7814\u7a76\u7d50\u679c\u306f\u5b66\u8853\u96d1\u8a8c\u3084\u5b66\u4f1a\u7b49\u3067\u767a\u8868\u3055\u308c\u308b\u4e88\u5b9a\u3067\u3059\u304c\u3001\u767a\u8868\u5185\u5bb9\u306b\u500b\u4eba\u3092\u7279\u5b9a\u3067\u304d\u308b\u60c5\u5831\u306f\u4e00\u5207\u542b\u307e\u308c\u307e\u305b\u3093\u3002<\/p>\n<p>\uff1c\u8a66\u6599\u30fb\u60c5\u5831\u306e\u7ba1\u7406\u8cac\u4efb\u8005\uff1e<br \/>\n\u3000\u3000\u611b\u5a9b\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662\u3000\u3000\u8133\u795e\u7d4c\u5916\u79d1\u3000\u3000\u6c0f\u540d\u3000\u4e95\u4e0a\u660e\u5b8f<\/p>\n<p>\u3055\u3089\u306b\u8a73\u3057\u3044\u672c\u7814\u7a76\u306e\u5185\u5bb9\u3092\u304a\u77e5\u308a\u306b\u306a\u308a\u305f\u3044\u5834\u5408\u306f\u3001\u3010\u304a\u554f\u3044\u5408\u308f\u305b\u5148\u3011\u307e\u3067\u3054\u9023\u7d61\u304f\u3060\u3055\u3044\u3002\u4ed6\u306e\u60a3\u8005\u3055\u3093\u306e\u500b\u4eba\u60c5\u5831\u306e\u4fdd\u8b77\u3001\u304a\u3088\u3073\u3001\u77e5\u7684\u8ca1\u7523\u306e\u4fdd\u8b77\u7b49\u306b\u652f\u969c\u304c\u306a\u3044\u7bc4\u56f2\u3067\u304a\u7b54\u3048\u3044\u305f\u3057\u307e\u3059\u3002<\/p>\n<p>\u3010\u304a\u554f\u3044\u5408\u308f\u305b\u5148\u3011<br \/>\n\u611b\u5a9b\u5927\u5b66\u5927\u5b66\u9662\u3000\u533b\u5b66\u7cfb\u7814\u7a76\u79d1\u3000\u8133\u795e\u7d4c\u5916\u79d1\u5b66\u3000\u8b1b\u5e2b\u3000\u4e95\u4e0a\u660e\u5b8f<br \/>\n791-0295\u3000\u611b\u5a9b\u770c\u6771\u6e29\u5e02\u5fd7\u6d25\u5ddd454<br \/>\nTel: 089-960-5338<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u304a\u77e5\u3089\u305b \u611b\u5a9b\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662\u3067\u306f\u3001\u533b\u5b66\u30fb\u533b\u7642\u306e\u767a\u5c55\u306e\u305f\u3081\u306b\u69d8\u3005\u306a\u7814\u7a76\u3092\u884c\u3063\u3066\u3044\u307e\u3059\u3002\u305d\u306e\u4e2d\u3067\u4eca\u56de\u793a\u3057\u307e\u3059\u4ee5\u4e0b\u306e\u7814\u7a76\u3067\u306f\u3001\u4ee5\u524d\u306b\u304a\u77e5\u3089\u305b\u81f4\u3057\u307e\u3057\u305f\u3088\u3046\u306b\u3001\u5f53\u79d1\u306b\u3066\u52a0\u7642\u3092\u884c\u3063\u305f\u60a3\u8005\u3055\u3093\u306e\u30ab\u30eb\u30c6\u8a18\u9332\u3084\u753b\u50cf\u60c5\u5831\u3092\u4f7f\u7528\u81f4\u3057\u307e\u3057 [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1423","post","type-post","status-publish","format-standard","hentry","category-news"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/neurosurgery\/wp-json\/wp\/v2\/posts\/1423","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/neurosurgery\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/neurosurgery\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/neurosurgery\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/neurosurgery\/wp-json\/wp\/v2\/comments?post=1423"}],"version-history":[{"count":1,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/neurosurgery\/wp-json\/wp\/v2\/posts\/1423\/revisions"}],"predecessor-version":[{"id":1424,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/neurosurgery\/wp-json\/wp\/v2\/posts\/1423\/revisions\/1424"}],"wp:attachment":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/neurosurgery\/wp-json\/wp\/v2\/media?parent=1423"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/neurosurgery\/wp-json\/wp\/v2\/categories?post=1423"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/neurosurgery\/wp-json\/wp\/v2\/tags?post=1423"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}